San Diego, CA, February 18, 2009 – Vascular BioSciences announced today that it was awarded US Patent No. 7,491,176 titled “A Kit for Obtaining an Endoarterial Biopsy Sample” on February 17, 2009 to Vascular BioSciences’ CEO David Mann.
VBS also previously awarded European Patent number EP 1331883B1 on Feb 20, 2008 for “A Kit for Obtaining an Endoarterial Biopsy Sample.”
The patent describes a kit for obtaining an endoarterial biopsy from a patient and business methods for the remote analysis of endoarterial biopsy samples.
David Mann, Vascular BioSciences CEO and sole inventor of the patents, said, “Cardiovascular catheterizations are often complex procedures that require a multitude of instruments and equipment to successfully complete the procedure. The endoarterial biopsy kit recognizes this need and provides a simple and logical way to streamline endoarterial biopsy procedures. At Vascular BioSciences, we aim to supply physicians with everything they need to perform percutaneous endoarterial biopsy procedures as well as provide them with powerful bioinformatic and analytical tools to interpret endoarterial biopsy information on a histological and molecular level in order to enhance and prolong the lives of their patients.”
About Vascular BioSciences
Vascular BioSciences, a diversified biomedical company with operations in California and North Carolina, provides disease solutions in order to enhance and prolong human life.
Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides molecular diagnostic services, and through it’s majority owned subsidiary VBS Pharmaceuticals, develops targeted therapeutics for patients with difficult to treat diseases.